Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    19718025 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Terminated
Has Results
Lapatinib in Stage IV Melanoma With ERBB4 Mutations
Condition: Malignant Melanoma
Intervention: Drug: Lapatinib

Study has passed its completion date and status has not been verified in more than two years.